ADMA Biologics ADMA Cost Of Revenue
Cost Of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's cost of revenue?
- ADMA Biologics (ADMA) reported cost of revenue of $33.74M in Q1 2026.
- How has ADMA Biologics's cost of revenue changed year-over-year?
- ADMA Biologics's cost of revenue decreased by 37.2% year-over-year, from $53.71M to $33.74M.
- What is the long-term trend for ADMA Biologics's cost of revenue?
- Over 2 years (2023 to 2025), ADMA Biologics's cost of revenue has grown at a 13.3% compound annual growth rate (CAGR), from $169.27M to $217.41M.
- What does cost of revenue mean?
- Includes the direct costs attributable to the production of the goods sold or services provided by a company. This typically encompasses raw materials, direct labor, and manufacturing overhead, providing insight into production efficiency and cost control.